The common oral bacterium Streptococccus sanguis can degrade arginine via the arginine deiminase (AD) system. The three enzymes of this system, AD, ornithine carbamyltransferase (OTC), and carbamate kinase (CK), catalyze the breakdown of arginine to ornithine, C02, and two molecules of ammonia, with the production of ATP from ADP. The genes of the AD system, which are subject to complex regulation in the oral streptococci, have been isolated in bacteriophage lambda by screening for AD activity. The AD gene, designated arcA, was expressed from recombinant bacteriophage or in cells harboring plasmid subclones from this phage at a level up to 1,000-fold lower than the level in fully derepressed S. sanguis but apparently under the control of its own promoter. By subcloning in Escherichia coli mutants defective in anabolic OTC (argF argL) and CK (carB), it was demonstrated that the genes for S. sanguis OTC and CK were located adjacent to the AD gene. The levels of expression of the OTC and CK genes (arcB and arcC, respectively) were also very low in E. coli, although arcC expression was not as poor as arcA and arcB expression when compared with the levels found in S. sanguis. Also, arcB and arcC were unable to complement the defects in their anabolic counterparts. Introduction of the entire AD system or subclones which encoded only the AD gene into E. coli harboring defects in arginine and pyrimidine biosynthesis resulted in a 10-to 15-fold decrease in the level of AD activity, suggesting that arginine or its metabolites may regulate AD expression. Transposon mutagenesis was utilized to construct defined mutants of S. sanguis with mutations in the AD gene cluster. AD gene expression in these mutants indicated that the expression of the AD genes in this organism is strongly interrelated. The isolation and partial characterization of the arc genes represents the first step in the genetic manipulation of the AD system in the oral streptococci for analysis of the regulation of AD, analysis of the role of the system in plaque ecology, and utilization of the system to modulate the cariogenicity of dental plaque.
A variety of bacteria, including members of the genera Streptococcus, Bacillus, Pseudomonas, Clostridium, Lactobacillus, Treponema, and Mycoplasma, are able to utilize arginine, catabolically, via the arginine deiminase (AD) system (1, 13). Many of these organisms can utilize arginine as a sole source of energy for growth (1, 13, 42, 47) . The AD pathway involves three main enzymes. AD catalyzes the hydrolysis of arginine to citrulline and ammonia. Then, catabolic ornithine carbamyltransferase (ornithine transcarbamylase; OTC) catalyzes the reaction of citrulline with inorganic phosphate to produce ornithine and the highenergy compound carbamyl phosphate. The final step in the pathway is catalyzed by catabolic carbamate kinase (CK), which can transfer the phosphate group of carbamyl phosphate to ADP to produce ATP, with the concomitant production of ammonia and CO2. Anabolic variants of OTC and CK are widely distributed among procaryotes and eucaryotes, in which they function in arginine and pyrimidine biosyntheses (13, 18) .
The AD system plays important roles in cell physiology and is subject to fairly complex genetic and biochemical regulation. For example, in Pseudomonas aeruginosa, catabolism of arginine facilitates fermentative growth on arginine, with ATP being derived from the reaction catalyzed by CK (1, 13, 47) . Genetic regulation of the AD system by oxygen, arginine, glucose, and cellular energy levels has been observed in a variety of organisms, such as P. aeruginosa, Streptococcus faecalis, Bacillus licheniformis, and some lactic streptococci (1, 13, 35, 39, 43, 47) . The genes for stems from an intention to manipulate the AD system genetically in plaque bacteria so that the resulting organisms will be able to colonize the teeth and modulate the cariogenicity of dental plaque by catabolizing arginine. For example, with the isolation of the genes from S. sanguis, it should be possible to introduce the AD system into the cariogenic bacterium S. mutans (20, 29) , which lacks the AD system. These recombinant organisms should have a selective advantage because of their ability to produce one molecule of ATP per molecule of arginine catabolized. As an alternative strategy, the AD genes could be altered in vitro to be more highly expressed or nonrepressible by glucose and then returned to S. sanguis. The ammonia-producing streptococci not only should be less cariogenic themselves but also could reduce the overall cariogenic potential of dental plaque. The general approach of using replacement therapy in the prevention of dental caries has been explored by others with Streptococcus salivarius (45) and lactate dehydrogenasedeficient S. mutans (21) and has the advantage that these organism may be effective when cariostatic agents, such as fluoride, are only moderately effective, for example, in pit and fissure caries or caries in interproximal surfaces (20, 29) .
The AD system appears to be a major contributor to the rise in plaque pH that normally occurs after glycolytic acidification. In fact, the pH of plaque normally rises above that of the saliva which bathes it (2, 25). The abilities of S. sanguis and other plaque bacteria to degrade salivary proteins and peptides were clearly demonstrated (11, 25, 41) , and the arginine liberated from salivary proteins was degraded, primarily via the AD pathway (25) . Studies have demonstrated that arginine and arginine-containing compounds are far more effective than other amino acids or peptides at inhibiting the pH drop following a sugar challenge and in eliciting a subsequent pH rise (25, 49, 50) . Sialin, an arginine-containing tetrapeptide found in saliva, was particularly effective (25) , even at concentrations as low as 40 ,uM. Fractionation of salivary proteins indicates that although the amount of arginine in free or bound form in saliva is low, there is a high proportion of arginine in the low-molecular-mass fractions (<10 kilodaltons) which presumably can readily diffuse into plaque and be metabolized by S. sanguis (11, 25) . Well-characterized peptides such as the histatins, which have a low molecular mass (3 to 5 kilodaltons), represent a major proportion of total salivary secretions. They bind with high affinity to the tooth surface and are composed of approximately 10 to 12.5 mol% arginine (37) . Thus, ammonia production from arginine by oral streptococci, such as S. sanguis and Streptococcus mitior, could play a direct, ameliorative role in the initiation and progression of dental caries.
Studies focusing on differences in the plaques of cariesresistant and caries-prone subjects (2, 11, 25) indicated that there were few differences in the abilities of plaques from these individuals to effect a pH drop when challenged with a fermentable carbohydrate but that there were significant differences in the environmental pH rise following acidification (11, 25) . More recently (A. Naini and I. D. Mandel, J. Dent. Res. 68:318, 1989 ), significant differences were found in the abilities of plaques from caries-resistant and cariesprone individuals to produce ammonia and effect a pH rise when given arginine in vitro. These studies suggest that one of the key factors in inhibiting dental caries may be a function of the capacity for dental plaque to produce ammonia from arginine in salivary peptides.
Despite its probable importance in oral ecology and disease processes, little is known of the genetic regulation, biochemistry, and physiology of the AD system in oral streptococci. As described in this report, the genes encoding the enzymes of the AD system have been isolated by molecular cloning, and defined mutants of the AD system have been constructed. The cloning, organization, and peculiarities of expression in Escherichia coli of the genes for the S. sanguis AD pathway are described, and the potential utility of the manipulation of the AD system for caries prevention is discussed.
MATERIALS AND METHODS
Bacterial strains, bacteriophage, plasmids, and growth medium. The bacterial strains and plasmids used in this study are listed in Table 1 . E. coli strains were maintained on L (36) or MacConkey medium supplemented, when necessary, with 50 ,ug of ampicillin, 50 ,ug of kanamycin, or 10 ,ug of chloramphenicol per ml. Liquid cultures were grown in L broth or in TB medium, a rich medium consisting of 12 g of tryptone, 24 g of yeast extract, and 4 ml of glycerol in 1 liter of 0.1 M potassium phosphate buffer (pH 7.0). Ampicillin or chloramphenicol was added to 50 or 10 ,ug/ml, respectively. Manipulations of bacteriophage lambda were done as described by Maniatis et al. (33) . For identification of AD-VOL. 57, 1989 on October 28, 2017 by guest http://iai.asm.org/ Downloaded from producing clones in the lambda library, phage were plaqued on the appropriate recipient on YT (33) medium supplemented with 1.0% arginine, 0.2% glucose, and 0.1% 2,3,5-triphenyltetrazolium chloride. The plates were incubated anaerobically for 48 h in a GasPak jar (BBL Microbiology Systems, Cockeysville, Md.). S. sanguis strains were maintained on brain heart infusion (BHI) agar and grown in BHI broth supplemented, when necessary, with 5 ,ug of erythromycin per ml. For assessment of AD system enzyme levels, S. sanguis was grown under derepressing conditions in BHI broth plus 0.8% galactose and 1.0% arginine. All medium components were from Difco Laboratories, Detroit, Mich., and supplements were purchased from Sigma Chemical Co., St. Louis, Mo.
DNA manipulations and genetic techniques. Chromosomal DNA was prepared from S. sanguis NCTC 10904 as previously described (6, 10) . Partial Sau3AI fragments of S. sanguis DNA, enriched for 12-to 17-kilobase-pair (kbp) fragments by sucrose gradient centrifugation, were cloned into the BamHI sites of the left and right arms of X-EMBL3, the DNA was packaged in vitro with a kit (Promega Biotec, Madison, Wis.), and appropriate E. coli strains were infected as outlined by the supplier.
CsCl-banded plasmid DNA was prepared as previously described (19) . Recombinant plasmids were screened in E. coli DH5a by the protocol of Holmes and Quigley (23) . Plasmid DNA prepared by this method was digested with restriction enzymes without further purification. Mapping and subcloning experiments were done with restriction enzymes and T4 DNA ligase (Bethesda Research Laboratories, Inc., Gaithersburg, Md.) under conditions recommended by the supplier. E. coli was transformed by the CaCl2 method (32) , and transformants of S. sanguis were obtained essentially as described by Lawson and Gooder (27) .
Transpositional mutagenesis of cloned genes was accomplished as described by Kuramitsu (26) . Mu dE is a mini-Mu derivative (9) of bacteriophage Mu which contains a Kmr determinant for use in E. coli and an Emr determinant that functions in the oral streptococci. Briefly, plasmids (encoding Cm9 harboring known restriction fragments were introduced by transformation into E. coli 730B, which harbors the thermally inducible Mu dE. Cultures were grown to the mid-exponential phase at 30°C, and phage induction and concomitant transposition were achieved by shifting the temperature to 42°C for 5 min, followed by incubation at 37°C for 2 h. The resulting phage lysate was treated with CHC13 and used to infect the recipient, E. coli M8820 (9) . Transductants harboring plasmids which contained transposon insertions were selected on medium supplemented with kanamycin and chloramphenicol. Plasmid DNA was prepared from the transductants by the rapid boiling method (23) , and the insertion site of the transposon was mapped with BamHI or HindIII. Plasmids thus prepared were linearized with an appropriate restriction enzyme and used to transform competent S. sanguis NCTC 10904, and transformants were selected on BHI plates with 10 ,ug of erythromycin per ml.
Enzyme preparation and assays. Phage lysates for assay of AD system enzymes were prepared by infecting E. coli LE392 with X EMBL3 or recombinant phage in the midexponential phase of growth at a multiplicity of infection of 5. For measurement of enzyme levels in E. coli harboring recombinant plasmids, cells were sonicated and centrifuged at 37,000 x g for 30 min at 4°C (6) , and the supernatant fraction was used for assays. AD system enzyme levels in S. sanguis were measured in permeabilized cells (8) . Hexanoic acid was added to preparations at a final concentration of 10 mM. Samples were used directly or were stored at -20°C with no loss of activity for >1 month.
Enzyme assays were performed by standard methods. For the AD reaction, mixtures (500 ,ul) contained 25 mM arginine, 10 mM hexanoic acid, 50 mM Tris-maleate buffer (pH 6.0), and the protein or cell sample. Reactions were terminated by the addition of an equal volume of 10% trichloroacetic acid solution, and samples were centrifuged at 12,700
x g for 1 min. The citrulline produced was measured in a reaction mixture containing 500 ,ul of trichloroacetic acidprecipitated sample, 700 pl of phosphoric acid-sulfuric acid (3:1), and 250 [lI of diacetyl monoxime (3, 17). This reaction mixture was boiled for 15 to 30 min. Citrulline standards were treated in the same manner. OTC was assayed in the direction of citrulline production (35, 43) . CK was assayed by measuring the production of ATP as previously described (43) Following plaque purification, recombinant and control phage were used to infect LE392. The resulting lysates were assayed for AD activity. One recombinant phage, X-AD1, was selected for further study because cells infected with it produced the highest levels of the AD enzyme. Cells which were infected with the X-AD1 recombinant phage produced a functional AD enzyme, while there was no detectable AD activity in cells infected with the vector, X-EMBL3 (Table 2) E. coli produces repressible, anabolic OTC and CK enzymes which are involved in arginine and pyrimidine biosyntheses (13, 18 c OTC activity was assessed in terms of citrulline synthesis. One unit is defined as the amount of enzyme required to synthesize one micromole of citrulline per hour from ornithine and carbamyl phosphate.
d CK activity was measured in bacteriophage lysates by measuring ATP synthesis from ADP and carbamyl phosphate. One unit is defined as the amount of enzyme required to produce one micromole of ATP per hour.
both OTC and CK, suggesting that the genes for the three enzymes of the AD system had been isolated on a single fragment. However, some compensatory increase in endogenous OTC and CK due to the depletion of arginine by AD could not be excluded.
Characterization of expression of the AD genes. Restriction mapping indicated that X-AD1 contained a 13-kbp insert, which was subsequently transferred to pUC19 as a single Sall fragment with the Sall sites present in the X-EMBL3 cloning vector. The resulting construction (Fig. 1) was designated pMAD1. pMAD1 was used to transform E. coli JM83, and transformants were used to prepare 37,000 x g soluble fractions. The AD gene was found to be expressed by E. coli (Table 3) . Similarly, the OTC and CK genes were expressed in E. coli JM83(pMAD1) at levels significantly higher than in the control [E. coli JM83(pUC19)]. The level Table 2 .
of expression of the AD gene in E. coli was found to be up to 1,000-fold lower than that in fully derepressed S. sanguis when permeabilized cells were used for assays (data not shown). The low levels of gene expression in E. coli were surprising because E. coli has been found to express streptococcal genes on multicopy plasmids particularly well (5, 7, 14) . The E. coli OTC and CK genes should have been repressed by arginine and/or uracil in the rich medium (18) . The observed increase in the levels of OTC and CK in strains harboring pMAD1 (Table 3) could possibly have been due to elevated levels of the endogenous E. coli enzymes. Therefore, pMAD1 was introduced by transformation into E. coli strains with arginine and pyrimidine biosynthesis defects. A mutant lacking OTC activity because of deletions in the argF and argl genes (E. coli N134) displayed low but measurable OTC activity when harboring pMAD1 (Table 3) . Likewise, E. coli JEF8, containing a deletion in the gene encoding the catalytic subunit of CK, carB, demonstrated consistently measurable CK activity when transformed with pMAD1. The CK gene product was not produced at levels as low as those of the products of the AD and OTC genes when compared with the levels found in S. sanguis. The data are consistent with reports indicating that the CK gene may be subject to additional levels of control in the oral streptococci (17, 24) and, therefore, independently regulated. The data clearly indicated that the genes for the three AD enzymes were located on pMAD1 and were clustered in the S. sanguis chromosome, perhaps similarly to the arc gene organization in P. aeruginosa (30) .
As previously mentioned, the poor expression of the AD gene in E. coli may have been due to insufficient free arginine in the cell to induce or derepress the gene. Recent data from our laboratory suggested that the levels of arginine in rich medium required to induce the system fully may be rather high (>10 mM). The results of the experiments with the argFI and carB mutants (Table 3) suggested but did not prove a lack of induction. The results did indicate that the introduction of pMAD1 into E. coli strains with deletions in both the argF and argI genes or in the carB gene resulted in a marked decrease in the expression of the AD gene. Levels of AD enzyme in these strains were around 10-to 15-fold lower than those found in an E. coli arginine prototroph (JM83). Of interest, the presence of the argF mutation in E. coli DH5a was associated with a three-to fivefold decrease in the level of AD gene expression. Also, although the levels of OTC and CK were clearly different (Table 3) between arginine prototrophs and auxotrophs, definite conclusions could not be drawn, since the relative contributions of the endogenous E. coli enzymes in JM83 to the observed OTC and CK levels were not known. Nevertheless, the levels of the AD gene product found in E. coli JM83, when compared with those in N134 and JEF8, were sufficiently different not to be accounted for by gene dosage.
The times in the culture cycle of E. coli harboring pMAD1 at which AD activity was detected indicated that the AD gene was subject to temporal regulation (Fig. 2) . Optimal expression did not occur until very late in the stationary phase. Expression during the exponential phase of growth was extremely low. The experimental data shown in Fig. 2 were obtained with E. coli DH5a, but regardless of the E. coli host chosen, expression of the genes for the AD system was very low or undetectable until late in the stationary phase. AD production in S. sanguis also occurs rather late in the growth cycle, even without catabolite repression.
Subcloning and mapping of the AD, OTC, and CK genes. To map the location of the AD gene on pMAD1, we generated a bank of subclones (Fig. 3) with the plasmid vector pMK4 (44) . These constructions were introduced into E. coli DH5a. A single 2.1-kbp HinclI fragment (pMAD-S47) was both necessary and sufficient for AD activity. The 3.0-kbp BamHI fragment present in pMAD-S18, which contains this HincIl fragment, also could serve to transform E. coli to the AD-positive phenotype. Subcloning of the AD gene did not result in enhanced expression indicative of a relief of repression, although E. coli cells harboring pMAD-S18 or pMAD-S47 did express slightly higher levels of AD activity than did cells carrying pMAD1. Slightly higher expression was observed for the subclones carried in other E. coli strains as well. This increase in AD activity likely was attributable to size differences and copy numbers of the various subclones.
Mapping of the OTC and CK genes was done by examining the expression levels of various subclones in the appropriate mutant strains. The 3.0-kbp BamHI fragment could render E. coli N134 OTC positive. The adjacent 3.7-kbp HinclI fragment was also demonstrated to be both necessary and sufficient for CK gene expression, albeit at a very low level. The levels of OTC and CK enzyme activity in these strains were comparable to those found in the appropriate ENZYME ACTIVI1T
Units Fig. 1 . ClaI sites (C) in pMAD-S18 and pMAD-S47 were used to determine the orientation of the insert. The arrows above each insert refer to the orientation of that fragment with respect to the orientation shown for pMAD1. The arrow and designation Plac denote the location and direction of transcription of the lac promoter. Cell extracts, assays, and unit definitions are as outlined in (Fig. 3) . Insertions were constructed as described in the text. Insertions 2, 11, and 18 map to the 2.1-kbp HincIl fragment, which expresses AD activity. Insertion 5 maps to the 3.7-kbp HinclI fragment, which expresses CK activity in E. coli JEF8. parent strain carrying pMAD1 ( Table 2 ), indicating that, as with AD gene, subcloning did not result in the alleviation of poor expression. Notably, the addition of arginine and uracil to the culture medium did not increase AD system gene expression from pMAD1 or its subclones.
The expression of the genes of the AD system from pMAD1 or any of its subclones was not influenced by induction of the lac promoter by isopropyl-p-D-thiogalactopyranoside (data not shown), suggesting that the AD, OTC, and CK genes were transcribed from their cognate streptococcal promoters. The AD and OTC genes could be transcribed either from separate promoters or as a polycistronic message, but the CK gene must have its own promoter, since it is unlikely that the construction pMAD-S42 could contain either the AD or the OTC promoter in the proper orientation.
Neither pMAD1 nor its subclones could complement the CK or OTC defects of N134 or JEF8, as measured by a conversion to prototrophy for arginine and/or uracil. The lack of complementation likely reflects the opposite regulatory influences on the OTC and CK genes of E. coli and S. sanguis; levels of expression are increased by depletion of arginine or pyrimidines for E. coli (13, 18) and excess arginine and depletion of glucose for S. sanguis (17) . Also, the streptococcal enzymes, like other catabolic OTC and CK proteins (1), may not function well in the anabolic direction.
Insertional inactivation with Mu dE. Bacteriophage Mu dE (26) was used to mutagenize the 3.0-kbp BamHI fragment encoding the AD gene. This phage is a construction of Mu dII 4041 (9) with a Kmr marker for use in E. coli and an Emr marker from Tn9J7 for use in the oral streptococci. Insertions were mapped with HindIII and BamHI. These constructions were linearized with EcoRI and introduced by transformation into S. sanguis NCTC 10904. The insertion designated 10904-mu2 resulted in the loss of AD activity, with a concomitant decrease in OTC function (Fig. 4 and Table 4 ). 10904-mull and 10904-mul8 resulted in a severe but not complete loss of AD activity, with decreased OTC activity, suggesting that these insertions are not located within the AD structural gene but perhaps define a regulatory region. These strains synthesized a functional CK gene product with CK activity 1.5-to 2-fold higher than that of the parent. Taken together, these data confirmed that subclones of this region encode AD and OCT. Recently, one of us demonstrated that the arcA and arcB genes described here show significant DNA sequence homology to the arcA gene of P. aeruginosa and the OTC genes of P. aeruginosa and E. coli (R. A. Burne, unpublished observations).
Mutants lacking CK activity were obtained by introducing insertions distal to the 2.05-kbp Hincll fragment encoding the AD gene in the adjacent 3.7-kbp HinclI fragment (Fig. 2) into S. sanguis. The resulting Emr transformants (Fig. 4) (10904-mu5) were completely devoid of CK activity (Table 4) and also produced abnormally low levels of AD and OTC. The data reinforced the observations that cells harboring pMAD1 and pMAD1-S42 express the S. sanguis CK gene and confirmed that the genes encoding the AD pathway enzymes are tightly clustered on the S. sanguis chromosome.
DISCUSSION
The genes encoding the three enzymes of the S. sanguis AD pathway have been isolated in bacteriophage lambda and subsequently transferred to pUC-based plasmids. The genes for the S. sanguis AD system, in keeping with the nomenclature adopted for the Pseudomonas AD genes (30, 46) , have been designated arcA (AD), arcB (catabolic OTC), and arcC (catabolic CK). Subcloning, mapping, and transposon mutagenesis studies have indicated that the genes for this pathway are tightly clustered on the S. sanguis chromosome, as they are on the P. aeruginosa chromosome. The results of Southern blot experiments with S. sanguis DNA and AD gene fragments indicated that there were no rearrangements of the AD genes during cloning (data not shown). Similar tight genetic linkages of coordinately regulated genes have been described previously in the oral streptococci (6, 14, 16) .
The low-level expression of the AD genes in E. coli is of particular interest, since it may provide insight into regulation in the streptococci. Previous reports describing the cloning and expression of genes from the oral streptococci indicated that the genes are highly transcribed and translated by E. coli (5, 7, 14) , presumably because streptococcal promoters and ribosome-binding sites function well in E. coli (14) . The genes for the AD system, particularly arcA and arcB, are poorly expressed in E. coli, and the gene products are not detectable until very late in the stationary phase. The simplest interpretation is that the regulatory elements of the AD genes are not efficiently recognized by E. coli. Therefore, the genes are expressed at low levels, and the late appearance of AD, OTC, and CK is due to the slow accumulation of stable gene products. Another possibility is that the genes are positively regulated in S. sanguis and that a regulatory element is missing from our clones. In fact, there is indirect evidence that such a regulator exists in P. aeruginosa (47) coli would support the view that free arginine or a metabolite of arginine may be involved in regulation of the system (1, 13, 17, 35, 43) . A decrease in cytoplasmic ATP levels could also regulate AD gene expression in E. coli, as previously suggested for other organisms (35, 43) . On the basis of the mapping data, it is unlikely that the 2.1-kbp HinclI fragment encodes a repressor protein. Established models for transcriptional attenuation or autogenous regulation could explain our observations. For example, late in the growth phase, levels of free arginine from proteolytic breakdown may be sufficiently high to induce the AD genes. Alternatively, a decrease in ATP levels could modulate transcription. Consistent with either the attenuator or autogenous regulation model is the inability to remove low-level expression by subcloning of the arcA gene. Yet another possibility is that there is a posttranslational processing step which occurs in the oral streptococci but not in E. coli and which is required for the optimal expression or function of the AD system. Membrane-associated forms of AD have been found in Mycoplasma hominis (28) , and we have found that a significant amount of S. sanguis AD activity is associated with the membrane fraction of S. sanguis. No evidence of such an association with membranes of E. coli harboring pMAD1 or its derivatives has been detected. Clearly, because of the complexity of the regulation of the AD system, studies done with DNA sequencing and gene fusions coupled to protein studies are needed to address poor expression in E. coli as well as AD gene regulation in S. sanguis.
The effects of Mu dE insertions were consistent with the mapping and biochemical data obtained in this study and confirm that the genes expressed in E. coli are the S. sanguis AD genes. The insertional mutagenesis data suggest that, in vivo, the genes could be transcribed as an operon, with the gene order being arcCAB, or that arcAB and arcC are divergently transcribed. However, subcloning and expression of the AD and OTC genes, apparently under the control of their own promoter(s) and in the absence of the arcC gene and its promoter, argue against a three-gene operon model. Moreover, relatively little is known about the metabolites and proteins which govern the expression of this gene cluster such that down-regulation of the arc genes, as seen with 10904 mu-5, may occur in response to accumulation or depletion of a metabolite rather than to polar effects or disruption of regions harboring divergent promoters. Additionally, CK may be regulated by factors unrelated to the AD system since, in addition to ATP synthesis, carbamyl phosphate can participate in the synthesis of intracellular polysaccharides by serving as a phosphate donor to free glucose (24) . Data presented here and elsewhere (17, 24, 43) support the idea that arcC is probably subject to regulation either coordinately or similarly to the arcA and arcB genes but could respond to other influences independently of the arcA and arcB genes. Because of this complex regulation and because so little is known about mediators of AD expression, a detailed study with insertional mutagenesis could yield misleading results. Recently, the S. sanguis AD and OTC proteins were purified (R. A. Burne, unpublished results). These proteins are approximately 50 and 35 kilodaltons, respectively, similar to other AD and OCT proteins (1, 30) . If the CK gene product is similar in molecular size to the P. aeruginosa or S. faecalis protein (35 to 39 kilodaltons) (1, 30) , then the entire AD gene cluster would be predicted to occupy only 3 to 3.5 kbp. It is quite reasonable to couple DNA sequencing with functional studies to dissect the molecular bases of differential AD gene expression. Currently, the 3.0-kbp BamHI fragment is being sequenced.
The mini Mu-derived AD mutants of S. sanguis will be useful for a number of other studies. Defined AD system mutants can be used in in vitro studies to determine the role of the AD system in the physiology and acid tolerance of S. sanguis. Studies with "mixed plaques" in continuous cultures (M. Bartels, M.S. thesis, University of Rochester, Rochester, N.Y., 1986) can also be used to assess the role of the system in the competitiveness of S. sanguis. The ability of such mutants to cause caries can be assessed in the rat caries model. All of these studies could logically be extended to other oral streptococci, such as Streptococcus rattus and S. mitior, which possess the system. One of our objectives is to construct S. mutans strains which have been genetically engineered to contain the AD system. These ammonia-producing streptococci could then be tested in animal models for their ability to (i) successfully implant; (ii) compete with plaque bacteria; and (iii) modulate plaque cariogenicity in such a way that they result in a net reduction in the amount of dental disease. Construction of strains of S. mutans with the AD system integrated into the chromosome is under way. The gtfA gene, cloned by a number of laboratories (5, 6, 40) and of known nucleotide sequence (16) , has been selected as the site for integration in the initial test system, although alternative strategies can be used. Importantly, there should be nothing particularly detrimental to S. mutans strains which possess the AD system, since S. rattus, the closest relative of S. mutans among the oral streptococci (12) , has the AD system and is frequently isolated from the human mouth (20, 29) . However, optimization of these genetically engineered strains for implantation would undoubtedly be necessary and could be accomplished by passage on surfaces in continuous cultures or in gnotobiotic animals.
Another strategy which is a logical spinoff of the use of the AD system in S. mutans would be to introduce a bacterial urease into S. mutans. Urea is found in micromolar to millimolar quantities in saliva and in very high quantities in dialysis patients (38, 49, 50) . High salivary urea levels have been associated with a lower caries incidence (38) . Ureolytic organisms have been isolated in plaque, and a correlation between their presence and an inhibition of plaque acidification has been described (25, 49, 50) . It should be possible to obtain a bacterial urease, perhaps from plaque bacteria, which could function when expressed in an organism such as S. mutans or S. sanguis. These strategies represent novel and potentially very powerful methodologies for the prevention of dental caries, and such methodologies should be applicable to other oral diseases such as root surface caries and periodontal disease.
